Viracta Therapeutics Inc (NASDAQ:VIRX) currently has a daily average trading volume of 643.09K but it saw 1319976 shares traded in last market. With a market cap of 9.58M USD, the company’s current market price of $0.24 came rising about 2.84 while comparing to the previous closing price of $0.24. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.31 and as low as $0.20. In the recent trading on the day, stock has struck highest price mark of $0.2315 while lowest mark touched by it was $0.2496.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which downgraded the stock as “Market Perform” in its note to investors issued on August 16, 2024, recommending a price target of between $5 and $3 for it. H.C. Wainwright issued its recommendations for the stock as it initiated the price target for the stock is $35.
Over the week, VIRX’s stock price is moving 8.58% up while it is 8.00% when we observe its performance for the past one month. Year-to-date it is -57.37% down and over the past year, the stock is showing a downside performance of -65.34%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.33 beaten by the consensus estimate of -0.3 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of -0.24 while estimate for next year EPS is -0.87.
Currently, Viracta Therapeutics Inc’s total number of outstanding shares is 39.09M. Company’s return on investment (ROI) stands at -1697.34% and return on equity (ROE) at -208.67%. Stock’s beta reads 0.71. Its return on asset (ROA) is -83.82% on average.
